Why it was recalled
Chemical Contamination: Bottles may contain broken dessicants
Product description
Hyoscyamine Sulfate Sublingual Tablets, 0.125 mg, packaged in 100-count bottles, Rx only, Manufactured for: Virtus Pharmaceuticals OPCO II, LLC. Nashville, TN 37217. NDC 76439-0309-10
Lot numbers, UPCs & expiration codes
Lot #: 638J011A
Where it was sold
Nationwide & Puerto Rico.
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-1044-2016
- Classification
- Class III
- Status
- Terminated
- Recall initiated
- May 13, 2016
- FDA report date
- Jun 29, 2016
- Quantity
- 24,614 bottles
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Virtus Pharmaceuticals, Llc
Original FDA data
Every field from FDA enforcement report D-1044-2016, exactly as published.
Show all FDA fields
- City
- Tampa
- State
- FL
- Status
- Terminated
- Country
- United States
- Event ID
- 74251
- Address
- 2649 Causeway Center Dr
- Code information
- Lot #: 638J011A
- Postal code
- 33619-6102
- Report date
- Jun 29, 2016
- Product type
- Drugs
- Recall number
- D-1044-2016
- Classification
- Class III
- Recalling firm
- Virtus Pharmaceuticals, Llc
- Product quantity
- 24,614 bottles
- Termination date
- Aug 21, 2018
- Reason for recall
- Chemical Contamination: Bottles may contain broken dessicants
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Hyoscyamine Sulfate Sublingual Tablets, 0.125 mg, packaged in 100-count bottles, Rx only, Manufactured for: Virtus Pharmaceuticals OPCO II, LLC. Nashville, TN 37217. NDC 76439-0309-10
- Distribution pattern
- Nationwide & Puerto Rico.
- Recall initiation date
- May 13, 2016
- Initial firm notification
- Center classification date
- Jun 20, 2016